SCHEMBL5269154

SCHEMBL5269154

COC(=O)C(=O)CC(=O)c1ccn(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
POLB P06746 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ERCC5 P28715 5/20 0.34
FEN1 P39748 5/20 0.34
PTPN1 P18031 1/20 0.34
KMT2A Q03164 4/20 0.33
KCNH2 Q12809 2/20 0.32
ALOX15 P16050 2/20 0.31
MAPK1 P28482 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
LMNA P02545 1/20 0.31
APEX1 P27695 1/20 0.31
RECQL P46063 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPC1 O15118 1/20 0.31
HAO1 Q9UJM8 1/20 0.31
SLC18A3 Q16572 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325386 0.83 KMT2A (0.43) ALDH1A1POLBSMN1; SMN2KMT2AALOX15
SCHEMBL4342076 0.79 KMT2A (0.39) ALDH1A1SMN1; SMN2ERCC5FEN1PTPN1
SCHEMBL9585713 0.79 CES2 (0.36) ALDH1A1SMN1; SMN2KMT2ATDP1NPC1
SCHEMBL20523112 0.75 ALDH1A1 (0.48) ALDH1A1POLBSMN1; SMN2KMT2ANPC1
SCHEMBL7186586 0.75 KLKB1 (0.44) SMN1; SMN2ERCC5FEN1PTPN1KMT2A
SCHEMBL12094828 0.74 MAPT (0.42) ALDH1A1POLBSMN1; SMN2KMT2AMAPK1
SCHEMBL1527228 0.74 TSHR (0.48) ALDH1A1POLBKMT2AALOX15TDP1
SCHEMBL5266327 0.73 PKM (0.60) ALDH1A1KMT2AMEN1
SCHEMBL1109662 0.73 ERCC5 (0.64) ALDH1A1POLBSMN1; SMN2ERCC5FEN1
SCHEMBL7502013 0.73 GSK3B (0.48) PTPN1SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 ALDH1A1 111/4885POLB 4340/4885SMN1; SMN2 3490/4885
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 ALDH1A1 171/4885POLB 4082/4885SMN1; SMN2 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.